Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
DAWN
DAWN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DAWN News
DAY ONE BIOPHARMACEUTICALS ANTICIPATES TOPLINE RESULTS FROM FIREFLY-2 CLINICAL TRIAL BY MID-2027
2d ago
moomoo
DAY ONE AND SERVIER FINISH ENROLLMENT IN KEY PHASE 3 FIREFLY-2 TRIAL OF TOVORAFENIB FOR FRONT-LINE TREATMENT OF PEDIATRIC LOW-GRADE GLIOMA (PLGG)
2d ago
moomoo
Servier Completes Acquisition of Day One Biopharmaceuticals
Apr 23 2026
PRnewswire
Servier Completes Acquisition of Day One Biopharmaceuticals
Apr 23 2026
PRnewswire
Servier Completes Acquisition of Day One Biopharmaceuticals
Apr 23 2026
PRnewswire
Investor Rights Law Firm Investigates Multiple Companies
Apr 09 2026
PRnewswire
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
Mar 27 2026
PRnewswire
M&A Deal Closures Present Opportunities: Target Janus Henderson and Other Stocks.
Mar 25 2026
Barron's
Opportunities Arise from Finalizing M&A Deals: Target Janus Henderson and Other Stocks.
Mar 25 2026
Barron's
Global Oncology Market Set for Rapid Growth
Mar 19 2026
PRnewswire
Global Oncology Market Expected to Reach $748.17 Billion
Mar 19 2026
Newsfilter
Investor Rights Law Firm Investigates Multiple Companies
Mar 12 2026
PRnewswire
Monteverde Law Firm Investigates Multiple Biopharma Companies
Mar 12 2026
Globenewswire
Wall Street Analysts Adjust Ratings
Mar 11 2026
Benzinga
Monteverde Law Firm Investigates Multiple Biopharmaceutical Companies
Mar 10 2026
Globenewswire
Wall Street Analysts Adjust Ratings
Mar 10 2026
Benzinga
Show More News
